https://orcid.org/0000-0001-8010-0682
References
- Chen JR, Lin Q, Friis I, Wilmot-Dear CM, Monro AK. 2003. Flora of China. Vol. 5. Beijing, China: Science Press; p. 78–84.
- Chinese Materia Medica Editorial Board. 1999. Chinese materia medica. Vol. 2. Shanghai, China: Shanghai Science and Technology Press; p. 584–585.
- Luu TT, Wang MY. 2015. Research progress on medical plants of Uritca L. Chin J Enthomed Enthopharm. 2015:16–24.
- Rajput P, Chaudhary M, Sharma RA. 2018. Phytochemical and pharmacological importance of genus Urtica – a review. Int J Pharm Pharm Sci. 9:1387–1396.
- Su XD, Li W, Ma JY, Kim YH. 2018. Chemical constituents from Epimedium koreanum Nakai and their chemotaxonomic significance. Nat Prod Res. 32(19):2347–2351.
- Tundis R, Loizzo MR, Menichini F. 2010. Natural products as α-amylase and α-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. MRMC Chem. 10(4):315–331.
- Wang MY, Yang Y, Zhou XY, Wang SS, Duan SX, Li XB. 2018. The chemical constituents from Urtica fissa leaves. J Asian Nat Prod Res. 20(8):709–718.
- Wang HB, Yu DQ, Liang XT, Watanabe N, Tamai M, Omura S. 1989. The structures of two lignan glycosides from Stauntonia chinensis. J Nat Prod. 52(2):342–345.
- Wang YM, Zhao JQ, Yang JL, Idong PT, Mei LJ, Tao YD, Shi YP. 2019. Antioxidant and alpha-glucosidase inhibitory ingredients identified from Jerusalem artichoke flowers. Nat Prod Res. 33(4):584–588.
- Yan X-G, Jia J-M, Tang L, Shi L-Y, Wang Y-Q, Feng B-M. 2008. New chemical constituents of roots of Urtica triangularis hand-mass. Chem Pharm Bull. 56(10):1463–1465.